RN7SKP253

Across TCGA pan-cancer cohorts, RN7SKP253 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RN7SKP253’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RN7SKP253 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SKP253 is over-expressed in tumor, although a few such as KIRP show the opposite, repressed pattern.

THCA and KIRP are the cancer types where RN7SKP253 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SKP253 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	III,IV	+0.091	.032	1	view →
KIRP	All	All	−0.028	.021	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RN7SKP253–THCA

Open the THCA breakdown →